← Back to Search

Moderate to vigorous physical activity for Atherosclerosis (MoMA Trial)

N/A
Waitlist Available
Led By Eric Larose, DVM, MD
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 year, 2 years
Awards & highlights

MoMA Trial Summary

Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis

MoMA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year, 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 year, 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in carotid vessel wall volume measured by magnetic resonance imaging (MRI)
Secondary outcome measures
Change in BMI
Change in CRP
Change in IL-6
+16 more

MoMA Trial Design

3Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Continued inactivity
Group II: Moderate to vigorous physical activityActive Control1 Intervention
MVPA (55-90% of maximum heart rate) for 150 min/week (current recommendations)
Group III: Light physical activityActive Control1 Intervention
LPA (40-55% of maximum heart rate) for 150 min/week

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
416 Previous Clinical Trials
172,128 Total Patients Enrolled
2 Trials studying Atherosclerosis
693 Patients Enrolled for Atherosclerosis
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,338 Previous Clinical Trials
25,751,389 Total Patients Enrolled
5 Trials studying Atherosclerosis
3,641 Patients Enrolled for Atherosclerosis
Eric Larose, DVM, MDPrincipal InvestigatorInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis
Eric Larose, DVM, MD, FRCPC, FCCS, FAHA 2015. "Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02628275.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top